Risk adapted moderate hypofractionation of low, intermediate and high risk prostate cancer - feasibility, QOL, acute toxicity and outcome
Wolf, F; Schörghofer, A; Sedlmayer, F;
Risk adapted moderate hypofractionation of low, intermediate and high risk prostate cancer - feasibility, QOL, acute toxicity and outcome. 2018; -ÖGRO Jahrestagung 2018; 28.-29.09.2018; Salzburg.
Abstracts (Zeitschrift)